title: Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behçet's disease.
authors.forename: H
authors.initials: H
authors.lastname: Direskeneli
authors.forename: I
authors.initials: I
authors.lastname: Fresko
authors.forename: V
authors.initials: V
authors.lastname: Hamuryudan
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000097:blood*; D016209:Interleukin-8 / Q000097:blood*; D008297:Male; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D007155:Immunologic Factors; D016898:Interferon-alpha; D015850:Interleukin-6; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha